IVX: IVAX Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IVX: IVAX Corporation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (75)	1/10/2006 1:48:08 PM
From: Jim Oravetz	Read Replies (1) of 78

Teva,Ivax:FTC Review Continues,Buyout To Close Soon DOW JONES NEWSWIRES January 10, 2006 12:18 p.m. JERUSALEM -- Teva Pharmaceutical Industries Inc. (TEVA) said the closing date of its proposed acquisition of Ivax Corp. (IVX) has been rescheduled. The pharmaceutical companies said in a joint press release Tuesday the U.S. Federal Trade Commission is still reviewing the consent order which Teva and Ivax signed related to the pending acquisition of Ivax. The companies said acceptance should be forthcoming shortly, and expect to close the merger later this month. The election deadline for making a cash or stock election under the merger agreement will be 5 p.m. EST on the first business day following announcement of the rescheduled closing date. Teva is buying Ivax for about $7.4 billion. The European Commission cleared Teva to acquire Ivax in November

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next